One of the principal mechanisms by which G-protein-coupled receptors evoke cellular responses is through the activation of phospholipase C (PLC) and the subsequent release of Ca 2+ from intracellular stores. Receptors that couple to pertussis toxin (PTX)-insensitive G proteins typically evoke large increases in PLC activity and intracellular Ca 2 + release. In contrast, receptors that use only PTX-sensitive G proteins usually generate weak PLC-dependent responses, but efficiently regulate a second effector enzyme, adenylyl cyclase. For example, in many cell types, agonist binding by the m4 muscarinic acetylcholine receptor (m4 receptor) results in a strong inhibition of adenylyl cyclase and very little stimulation of PLC activity or release of intracellular Ca 2+ . We have investigated whether the weak, PTX-sensitive stimulation of PLC activity by the m4 receptor can play a significant role in the generation of cellular responses. Results: We report here that PTX-sensitive Ca 2+ release mediated by the m4 receptor in transfected Chinese hamster ovary cells is greatly enhanced when endogenous purinergic receptors simultaneously activate a PTX-insensitive signaling pathway. Furthermore, m4-receptor-induced transcription of the c-fos gene (a Ca 2 +-sensitive response) is similarly potentiated when purinergic receptors are coactivated. These enhanced m4-receptor-dependent Ca 2 + responses do not require an influx of external Ca 2+ , and occur in the absence of detectable purinergic-receptorstimulated Ca 2+ release; they apparently require the activation of both PTX-sensitive and PTX-insensitive G-protein pathways. Measurements of phosphoinositide hydrolysis indicate that the enhancement of m4-receptormediated Ca 2 + signaling by purinergic receptors is due to a synergistic increase in agonist-stimulated PLC activity.
responses do not require an influx of external Ca 2+ , and occur in the absence of detectable purinergic-receptorstimulated Ca 2+ release; they apparently require the activation of both PTX-sensitive and PTX-insensitive G-protein pathways. Measurements of phosphoinositide hydrolysis indicate that the enhancement of m4-receptormediated Ca 2 + signaling by purinergic receptors is due to a synergistic increase in agonist-stimulated PLC activity.
Conclusions: These studies demonstrate that the potency of m4-receptor-mediated PLC signaling is highly dependent upon the presence or absence of other PLCactivating agonists. The ability of the m4 receptor to evoke a strong, but conditional, activation of PLC may allow this type of receptor to participate in a coincidence-detection system that amplifies simultaneous PLC-activating signals through a mechanism involving crosstalk between PTXsensitive and PTX-insensitive G-protein pathways.
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Background
Calcium ions are crucial intracellular messengers that modulate a wide variety of cellular functions, including secretion, muscular contraction, metabolism and gene transcription [1, 2] . These complex processes are mediated, at least partially, by the direct effects of Ca 2+ on biochemical targets, such as kinases, proteases, cytoskeletal proteins and vesicular proteins, as well as on ion channels. Because of the potent effects of Ca 2+ on cell physiology, the resting cytosolic Ca 2+ concentration ([Ca 2 +]i) is maintained at low levels --20-200 nM [3] -by a variety of pumps and exchange proteins located on the plasma membrane and on intracellular organelles. Increases in [Ca Many different neurotransmitters and hormones elevate [Ca 2 +]i by binding to receptors that interact with heterotrimeric guanine-nucleotide binding (G) proteins that in turn stimulate the activity of particular isozymes of phospholipase C (PLC) [2, 4] . Phosphatidylinositol 4,5-bisphosphate (PIP 2 ) is hydrolyzed by PLC to generate two second messengers: inositol 1,4,5-trisphosphate (IP 3 ), which mediates the release of Ca 2+ from intracellular stores, and diacylglycerol, a lipid activator of the serine/threonine-specific kinase family termed protein kinase C (PKC). The components of the biochemical pathways leading to PLC stimulation and intracellular Ca 2+ release include perhaps 50 or more receptors, as well as multiple G proteins and PLC isozymes [4] [5] [6] . However, much remains to be learned as regards the mechanisms by which cells can use multiple receptors, G proteins and PLC isozymes to generate particular Ca 2 +-release signals and other PLC-dependent responses.
At least two distinct pathways link G-protein-coupled receptors to PLC stimulation and intracellular Ca 2+ release within an individual cell [3, 7] . The G proteins in these pathways can be distinguished by their sensitivity to pertussis toxin (PTX), a bacterially-derived toxin that catalyzes the mono-ADP-ribosylation of certain G-protein ct subunits (G,) and thus uncouples them from their cognate receptors [8] . Analysis of receptor-stimulated, PLC-mediated signaling in primary tissues and cell lines has demonstrated that many receptors -including B2 bradykinin receptors, 5HTlc serotonin receptors and the ml, m3 and m5 muscarinic acetylcholine receptor subtypes -stimulate PLC and Ca 2 + release through PTX-insensitive G proteins [7, [9] [10] [11] . In contrast, other receptors -such as o2-adrenergic receptors, 5HTla serotonin receptors and the m2 and m4 muscarinic acetylcholine receptor subtypes -activate PLC and inhibit adenylyl cyclase entirely through PTX-sensitive G proteins [7, [11] [12] [13] [14] . In vitro reconstitution and celltransfection experiments indicate that PTX-insensitive PLC activation involves a direct interaction between the G, /11 class of G-protein ox subunits and the 31 isoform of PLC. In contrast, the PTX-sensitive pathway apparently requires the binding of G-protein [ 3 y (Gpy) subunits, presumably released by G i subunits, to either the 132 or the 3 PLC isoform [4, 5, [15] [16] [17] [18] [19] [20] .
The magnitude of a PLC response is determined by several factors, including receptor number and agonist concentration. However, studies of G-protein-mediated signaling in many different cell types suggest that the size of a PLC response is also highly dependent upon whether the PTX-sensitive or PTX-insensitive pathway is activated. Receptors that couple to PTX-insensitive G proteins typically generate large increases in PIP 2 hydrolysis and intracellular Ca 2+ release, whereas receptors that signal exclusively through PTX-sensitive G proteins usually evoke significantly smaller PLC responses [7, 12, 13] . In some cases, PTX-sensitive activation of PLC signaling is so limited that it can only be detected at high receptor levels and with large doses of agonist. For example, m4 muscarinic acetylcholine receptors (m4 receptors), which couple to PTX-sensitive G proteins, efficiently inhibit adenylyl cyclase at low doses of agonist, but only weakly stimulate PLC activity even at saturating agonist concentrations [11, 21, 22] . Thus, it is not clear whether the stimulation of PLC activity by the m4 receptor, or other functionally similar receptors, plays a significant role in the generation of cellular responses.
To explore the functional significance of PLC stimulation by the m4 receptor, we have investigated the regulation of this pathway within the context of other signals that may normally converge upon cells expressing this receptor subtype. As most cells express several different types of Gprotein-coupled receptor, it is likely that mechanisms exist that allow cells to integrate multiple agonist signals, and thus generate second-messenger and physiological responses that are distinct from those elicited by the individual agonists. Previous studies have shown that acetylcholine and ATP are frequently co-released at various synapses and may thus be involved in some form of signal integration [23, 24] .
We therefore tested whether ATP, acting via G-proteincoupled purinergic receptors, may influence signal transduction mediated by the m4 receptor in cells expressing both types of receptor. We found that agonist activation of m4 receptors, expressed in Chinese hamster ovary (CHO) cells, resulted in a small, PTX-sensitive release of intracellular Ca 2 + . Importantly, this response was greatly enhanced when endogenous purinergic receptors, which stimulate PLC via PTX-insensitive G proteins, were concurrently activated with ATP. Moreover, m4-receptorinduced transcription of the c-fos gene, which is a Ca 2 +-sensitive response, was also potentiated when purinergic receptors were simultaneously activated.
The synergistic effect of purinergic receptors on PLC activation did not require the influx of external Ca 2 + and occurred with little or no purinergic-receptor-stimulated Ca 2 + release. In addition, the co-activation of purinergic receptors failed to potentiate the Ca 2 + responses generated by the m3 receptor, suggesting that the enhancement of receptor-mediated PLC activation may require cross-talk between PTX-sensitive and PTX-insensitive G-protein pathways. Lastly, the results of PIP 2 hydrolysis assays indicate that the potent stimulation of m4-receptor-mediated Ca 2+ release by purinergic receptors resulted from a synergistic increase in agonist-induced PLC activity. Our results therefore demonstrate that the m4 receptor is a conditional, but potent, activator of Ca 2 + release, and suggest that this type of receptor may act in a 'coincidence detection system' that integrates and amplifies PLC-mediated signals originating from distinct receptors coupled to both PTX-sensitive and PTX-insensitive G proteins.
Results
Purinergic receptors enhance m4-receptor-mediated calcium signaling
Like several other types of receptor that couple selectively to PTX-sensitive G proteins, the m4 receptor caused only small increases in the [Ca 2 +]i in CHO cells treated with carbachol, a stable analog of acetylcholine (Figs la and 2a) [12, 13] . Carbachol concentrations above 10 pLM were required to elicit a detectable Ca 2 + response, and the carbachol concentration that gave a half-maximal response was at least 100 .LM (Fig. 2a) . In contrast to the weak responses evoked by carbachol, the activation of endogenous purinergic receptors by the application of ATP alone resulted in large, rapid and transient increases in [Ca 2 +]i that were half maximal at agonist concentrations of-5 RIM (Fig. lb and data not shown) . The addition of adenosine itself had no effect on [Ca 2 +]i (data not shown), and treatment of the cells with the P2 purinergic receptor antagonist suramin eliminated the ATP-mediated Ca 2+ transient ( Fig. lb; [25, 26] ), thus demonstrating that the potent Ca 2 + responses were mediated via the activation of G-protein-coupled purinergic receptors by ATP.
Interestingly, the m4-receptor-mediated Ca 2 + response was markedly enhanced when cells were first treated with ATP (Fig. lb) . Following ATP addition, carbachol evoked large and transient Ca 2 + increases that were often similar in magnitude and kinetics to those evoked by endogenous purinergic receptors. It was not essential 
Enhancement of the Ca
2+ response without detectable purinergic-receptor-induced Ca 2+ release or influx To discover whether the mechanism underlying the enhancement of agonist-induced Ca 2 + responses was dependent upon a Ca 2 + signal evoked by purinergic receptors, we determined the minimal dose of ATP required to potentiate m4-receptor-induced intracellular Ca 2 + release. Interestingly, enhancement of m4-receptorstimulated Ca 2 + transients was not dependent upon the magnitude of the purinergic-receptor-mediated release of intracellular Ca 2 +. For example, the carbachol-stimulated Ca 2 + response was maximally enhanced by low doses of ATP (100 nM) that did not result in a detectable change in [Ca2+]i (Fig. c) . Minimal activation of purinergic receptors by 100 nM ATP increased the magnitude of the peak Ca 2 + transients evoked by large doses of carbachol (1 mM), and resulted in significant responses even at agonist concentrations (<100 nM carbachol) that alone would fail to evoke any change in [Ca2+]i (Fig. 2a) . that the addition of ATP was followed by the addition of carbachol, because potent Ca 2+ signals were also evoked when both agonists were applied simultaneously ( Fig. d; and see below) . However, the enhanced responses did require the concurrent activation of both purinergic and m4 receptors, because carbachol failed to evoke significant Ca 2 + transients when ATP was removed from the bath before addition of the muscarinic agonist (Fig. le) . Moreover, addition of the muscarinic and purinergic antagonists atropine and suramin, respectively, blocked the Ca 2+ response evoked by their target receptors, as well as the enhanced Ca 2+ signal resulting from the concurrent agonist activation of both receptor types (Fig. lb) . Furthermore, pretreatment of cells with PTX abolished both the basal (carbachol alone) and the ATP-enhanced Ca 2 + responses mediated by the m4 receptor, although the purinergic-receptorstimulated Ca 2 + transients were not affected by the toxin (Fig. f, and data not shown) . Purinergic receptors therefore activate a PTX-insensitive pathway that causes a potent, but conditional, enhancement of m4 receptormediated Ca 2+ signaling without altering the receptor's G-protein specificity.
The increased Ca 2 + transients evoked by a wide range of carbachol concentrations occurred in the absence of any significant ATP-induced change in the affinity of the m4 receptor for carbachol (see Materials and methods). To test whether ATP receptors enhanced m4-receptormediated responses through a Ca 2 +-influx mechanism, the ATP-dependent potentiation of m4-receptormediated Ca 2 + release was measured in the absence of extracellular Ca 2 +. We observed no significant difference in the peak amplitude of the enhanced, carbacholinduced Ca 2 + transients measured in the absence of extracellular Ca 2+ , although there was a significant reduction in the late plateau phase of the response (Fig. 3a) . Thus, the synergistic increase in m4-receptor-stimulated Ca 2+ responses by purinergic receptors does not require a significant ATP-induced release of Ca 2+ from intracellular stores or Ca 2+ influx across the plasma membrane.
Enhanced Ca
2+ responses by activation of distinct G-protein pathways Because m4 receptors and endogenous purinergic receptors evoke Ca 2+ transients through PTX-sensitive and PTX-insensitive G proteins, respectively, we investigated whether the mechanism of agonist-enhanced Ca 2+ signaling requires an interaction between these two general classes of G proteins. In order to test whether purinergic receptors are able to enhance the Ca 2 + responses evoked by other receptors that stimulate PLC through PTX-insensitive G proteins, we treated CHO cells expressing the m3 receptor with 100 nM ATP and increasing doses of carbachol (Fig. 2b) . The doseresponse curves for m3-receptor-expressing CHO cells demonstrated that the co-activation of purinergic receptors had no effect on the magnitude or kinetics of carbachol-mediated Ca 2 + transients, even at carbachol concentrations that evoked sub-maximal Ca 2+ responses similar to those generated via the m4 receptor (Fig. 2a) .
To investigate whether small Ca 2+ transients evoked by PTX-sensitive G proteins could potentiate subsequent activated by the binding of an agonist to its receptor. Therefore, the potentiation of m4-receptor-dependent Ca 2 + signaling by purinergic receptors could be the result of an enhancement of various steps in this pathway, including agonist-stimulated PLC activation or IP 3 -induced release of Ca 2+ from intracellular stores. To determine whether the effect of purinergic receptors on m4-receptor-induced Ca
2+
signaling involves an enhancement in PLC activity, IP 3 levels were measured following the application of muscarinic and purinergic agonists. Stimulation of m4 receptors with 10 -tM carbachol resulted in a small, but consistent increase in IP 3 formation, whereas activation of purinergic receptors alone with a low dose of ATP (100 nM) had little or no effect on PIP 2 hydrolysis (Fig. 4) . As in the previous Ca 2 + -release assays, sequential treatment of cells with low doses of ATP followed by carbachol evoked a substantial increase in PLC activity; the resulting inositol phosphate levels were significantly larger than the sum of the responses evoked by either agonist alone (Fig. 4) . 
PTX-sensitive Ca
2+ responses, we pretreated cells with a dose of carbachol sufficient to produce a limited Ca 2 + increase (similar to that generated by 100 nM ATP), and tested whether this treatment was able to enhance the response evoked by a second application of carbachol. This analysis revealed that an initial Ca 2+ signal generated by the m4 receptor was unable to enhance subsequent carbachol-induced Ca 2 + responses (Fig. 3b) . Although the initial (10 LiM) carbachol application may have caused some desensitization of one or more steps in the signal transduction pathway, m4 receptors were still able to mediate small increases in [Ca 2 +]i when treated with a second (1 mM) dose of carbachol (Fig. 3b) . Thus, these experiments suggest that the enhancement of receptordependent Ca 2 + signaling in these cells may require crosstalk between PTX-sensitive and PTX-insensitive G-protein pathways.
Synergistic enhancement of PLC activation by m4 receptors and purinergic receptors
The release of Ca 2 + from internal stores is one output of an amplified, multi-step signaling pathway that is Because all of the known G-protein-regulated PLC isozymes are stimulated by Ca 2+ , we also investigated whether the synergistic increase in agonist-induced PLC activity required a Ca 2 +-influx signal. In the absence of extracellular Ca 2+ , co-activation of m4 receptors and purinergic receptors still evoked a synergistic increase in inositol phosphate formation, although the magnitude of the enhanced PLC response was substantially decreased (Fig. 4) . This reduction in PLC activity in the absence of extracellular Ca 2+ may be responsible for the decrease in the Ca 2+ response at late plateau phase, as seen in Figure 3a . However, these experiments suggest that the synergistic increase in PLC activity caused by the co-activation of m4 receptors and purinergic receptors (see Materials and methods for experimental details). Thus, these studies did not support the hypothesis that an m4-or purinergic-receptor-regulated kinase or phosphatase was involved in the mechanism of agonistenhanced Ca 2 + signaling, although such proteins or potentiating factors may exist but be unaffected by these pharmacological agents. Because the enhancement of m4-receptor-mediated Ca 2 + signaling by purinergic receptors occurred when ATP and carbachol were applied either sequentially or simultaneously, this process may depend on a rapid change in the phosphorylation state of a component within the PLC signaling cascade, or the production of a short-lived potentiating factor [27] . To test the possibility that PKC activity is involved in the enhancement of Ca 2+ responses, cells were treated with the PKC activator phorbol myristate acid (PMA,) or the PKC inhibitor staurosporine, prior to ATP and carbachol addition; neither treatment altered the ability of ATP to enhance carbachol-induced Ca 2+ transients. Similarly, addition of the serine/threonine-phosphatase inhibitors okadaic acid and calyculin, or the tyrosine-phosphatase inhibitor vanadate, did not alter the enhanced Ca 2 + responses or prevent the loss of potentiation resulting from the washout of ATP prior to carbachol application Enhanced c-fos transcription by co-activation of m4 receptors and purinergic receptors To investigate whether the enhancement of m4-receptormediated PLC activation is translated into an increased cellular response, we tested the effects of carbachol and ATP on induction of the c-fos immediate early gene. Previous studies have shown that neurotransmitters and pharmacological agents that elevate [Ca 2 +]i can stimulate transcription of the c-fos gene through a promoter sequence termed the Ca 2 +-response element [28] . To measure receptor-stimulated c-fos transcription, mRNA was isolated from serum-starved CHO cells, following brief incubations with ATP, carbachol or both agonists, and analyzed by filter hybridization with a c-fos probe. Treatment with a low dose of ATP (100 nM), insufficient to evoke an increase in PLC activity or intracellular Ca 2+ release, also failed to induce transcription of the c-fos gene (Fig. 5) . Incubation with 10 p.M carbachol induced a significant increase in c-fos mRNA levels; however, this response was enhanced more than two-fold when cells were treated with minimal doses of both ATP and carbachol (Fig. 5) . Thus, these results demonstrate that the increased magnitude of PLC-dependent signals evoked by co-activation of the m4 and purinergic receptors results in a substantial enhancement of at least one downstream cellular response -the transcriptional induction of an immediate early gene.
Discussion
Previous studies have not clearly shown whether the ability of the m4 receptor weakly to stimulate PLC activity and intracellular Ca 2+ release plays a significant role in the signal transduction pathways regulated by this type of G-protein-coupled receptor. The results presented here demonstrate that the m4 receptor is a conditional, but strong, activator of Ca 2+ signaling, and reveal a potentially important role for this receptor in the integration of concurrent agonist signals. We found that the magnitude of the Ca 2+ response evoked by the m4 receptor was dramatically increased when purinergic receptors were simultaneously treated with ATP. Moreover, the activation of purinergic receptors significantly enhanced the sensitivity of the cell to m4-receptor-mediated PLC activation over a wide range of carbachol concentrations without causing any significant change in the affinity of the m4 receptor for carbachol. Thus, when purinergic receptors were co-activated, substantial Ca 2+ release was evoked by low doses of carbachol (10-100 nM) that otherwise exclusively couple the m4 receptor to adenylyl cyclase inhibition [11] .
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In addition to potentiating the Ca 2 + response evoked by the m4 receptor, we found that co-activation of purinergic receptors also enhanced carbachol-induced transcription of the c-fos immediate early gene, an important output of Ca 2+ signaling in many cell types [28] . As acetylcholine and ATP are often co-released during synaptic transmission, it is possible that a similar enhancement of second-messenger-dependent responses occurs when m4 receptors and purinergic receptors are simultaneously activated in vivo. Thus, these studies strongly suggest that PLC is a significant downstream effector of the m4 receptor, and further demonstrate the importance of examining the functional properties of a given receptor within the context of other signaling pathways that may be simultaneously active within the same host cell. PIP 2 hydrolysis assays indicate that the enhancement of m4-receptor-dependent Ca 2+ release by purinergic receptors can be attributed to a synergistic increase in agonistinduced PLC activity. Because m4 receptors and purinergic receptors signal through PTX-sensitive and PTX-insensitive G proteins, respectively, it is likely that these receptors activate distinct PLC isozymes. Previous investigations have shown that several PLC isozymes can be activated by both G, and Gy subunits. However, in vitro studies suggest that G subunits released from PTX-sensitive G proteins may preferentially activate the 32 and 33 isozymes of PLC, whereas PTX-insensitive Ga, subunits of the Ga/ / class may preferentially stimulate PLC31 [17] [18] [19] (the presence of each of these PLC isozymes in the CHO cells used in this study has been confirmed by immunoblot analysis; R.C.C., unpublished observations). Thus, the enhanced Ca 2 + responses described here represent a form of crosstalk between the two principal G-protein pathways leading to PLC stimulation in this cell type. Furthermore, the ability of PTX to block the enhancement of m4-receptor-evoked Ca 2 + transients, and the failure of purinergic receptors to enhance the Ca 2 + responses generated by m3 receptors, both suggest that agonist-dependent potentiation of PLC signaling may actually require the activation of both PTX-sensitive and PTX-insensitive G-protein pathways.
The G-protein pathways involved in the cooperative enhancement of Ca 2+ signaling appear to converge at or before the level of PLC activation. It is possible that the biochemical mechanism underlying the enhanced responses involves a purinergic-receptor-induced increase in the efficiency, or intrinsic rate, with which the m4 receptor activates its substrate G proteins. As PTXsensitive PLC activation and adenylyl cyclase inhibition appear to be mediated by the same G proteins in CHO cells [29] , such a mechanism should enhance the ability of the receptor to regulate both effectors. However, the inhibition of adenylyl cyclase by the m4 receptor is unaffected by purinergic receptor signaling in these cells (R.C.C., unpublished observations).
An alternative mechanism for the cooperative enhancement of Ca 2 + signaling is that the co-activation of Our experiments did not, therefore, reveal a requirement for Ca 2+ in the mechanism underlying agonist-induced enhancement of PLC activity in CHO cells, although minimal or extremely brief and highly localized increases in [Ca 2 +]i could be involved in this process. Some potentiating factor other than Ca 2 + may contribute to the enhanced responses that we have described. However, the apparent requirement for the activation of both PTX-sensitive and PTX-insensitive G proteins suggests that the underlying mechanism involves one or more intrinsic differences between the two pathways linking m4 and purinergic receptors to the enhancement of PLC activity in these cells.
Previous attempts to understand the mechanisms by which cells interpret independent, but convergent, signal transduction pathways have led to the identification of certain proteins, termed coincidence detectors, that play key roles in the integration of temporally coincident input signals [30] . When two distinct signals are simultaneously received, coincidence detectors allow the cell to generate output signals that differ substantially from those generated by either input alone. Examples of coincidence detectors include type I adenylyl cyclase, the catalytic activity of which is synergistically enhanced through the binding of Ca 2 +-calmodulin and GTP-bound Gs, and the NMDA subtype of glutamate receptor, the channel activity of which is dependent upon glutamate and glycine binding, as well as membrane depolarization [30] . The potent enhancement of m4-receptor-induced Ca 2 + signaling evoked by the concurrent activation of purinergic receptors suggests that the signaling pathways regulated by these distinct receptor types may contain a coincidence detector. Our results suggest that the coincidence detector within this system may be a PLC isozyme, perhaps PLC32 or PLC,3. The activity of this PLC isozyme may be regulated by a primary signal generated by the m4 receptor -GPy subunits, perhaps -and modified by a secondary input provided by purinergic receptors. The secondary input could be a product of PLC metabolism generated by the PTX-insensitive pathway, or a downstream kinase or phosphatase. Alternatively, a secondary input may be provided directly by the Ga subunits that are released as a consequence of purinergic receptor activation. These PTX-insensitive Ga subunits may further stimulate PLC enzymes that are activated by Gy subunits derived from the m4 receptor pathway, in a manner somewhat analogous to Gas-and Gi3-dependent activation of type II adenylyl cyclase [31] . It is also possible that signals generated by the m4 receptor enhance the activity of the PLC isozyme, perhaps PLC,1, that lies within the purinergic receptor pathway. However, as even moderate doses of ATP alone are sufficient to evoke maximal Ca 2 + responses in these cells, this presumptive G q-regulated PLC isozyme may be more limited in its putative role as a coincidence detector.
The synergistic enhancement of carbachol-induced PLC signaling by purinergic receptors provides a novel insight into the general nature of signal transduction via the m4 receptor and other, functionally similar, G protein-coupled receptors. Although activation of Gcai proteins by the m4 receptor probably plays some role in reducing the basal level of cAMP within the cell, potent m4 receptormediated inhibition of adenylyl cyclase is most readily observed when the enzyme is concurrently activated by receptors that couple to the stimulatory Gas protein [32] . Similarly, robust activation of Ca 2 + responses by the m4 receptor is only evident when a weak, but coincident potentiating signal is provided via a distinct PLC-activating receptor. Thus, various G-protein-coupled receptor families may include subtypes, such as the m4 receptor, that frequently act as modulators of the signals produced by other receptors, rather than as transducers of independent signals.
Conclusions
Our results demonstrate that the m4 receptor is a potent, but conditional, activator of Ca 2 + signaling when a distinct type of G-protein-coupled receptor is simultaneously active. The enhanced PLC-dependent responses reported here require concurrent activation of m4 receptors and P2 purinergic receptors, and are of greater magnitude that the sum of the responses evoked by either receptor alone. Thus, the m4 receptor may participate in a coincidence-detection system that amplifies simultaneous PLC-activating signals generated by PTX-sensitive and PTX-insensitive G-protein pathways. Because cells may normally receive multiple hormonal and neurotransmitter signals in vivo, these findings suggest one mechanism by which the temporal information encoded in these signals can be integrated into distinct PLC-dependent responses.
Materials and methods
Materials
PTX was purchased from List Biochemical. ATP was obtained from Pharmacia. Fura-2AM and Plurionic F127 were purchased from Molecular Probes. All cell-culture materials were obtained from Gibco/BRL. Okadaic acid was kindly provided by T. Hastett. RNazol (Tel-Test) and a PolyATtractIII kit (Promega) were used for mRNA isolation. All other chemicals were purchased from Sigma.
Cell culture CHO cells were transfected with a plasmid containing a cDNA encoding the m4 receptor under the transcriptional control of the simian virus 40 early promoter, as previously described [7, 33] . Stable transfections were selected and amplified in 50 nM methotrexate; similar results were obtained with several independent cell lines expressing the m4 receptor (CHO-m4 cells). CHO cells expressing the m3 receptor (CHO-m3 cells) were constructed as described previously [14] . The transfected CHO cells expressed -1.6 x 105 and 4 x 105 receptors per cell, respectively, as determined by Scatchard analysis [11] . The specific activity of the receptors was 48 pmol mg -1 and 9 pmol mg -1 for the m3-expressing and m4-expressing CHO cell lines, respectively. To determine whether activation of purinergic receptors with 100 nM ATP altered the affinity of the m4 receptor for carbachol, competition-displacement experiments were conducted with [ 3 H]-N-methyl scopolamine and various doses of carbachol, using CHO-m4 cells that were either treated or not treated with 100 nM ATP. Triplicate determinations revealed that the m4 receptor displayed asingle-affinity state, with a Kd for carbachol of 16.4 ± 2.8 p.M in the presence of 100 nM ATP, and 9.2 ± 2 p.M in the absence of ATP.
Calcium imaging and cell treatment CHO cells were trypsinized and plated on glass coverslips 48 h before each experiment. For PTX pretreatment, cells were transferred to media containing 100 ng ml -of toxin and incubated for 12 h at 37 °C in 5 % CO 2 . Intracellular Ca concentrations were determined by ratiometric analysis as previously described [14, 29, 34] . Ca 2 + responses were averaged from 64 cells per experiment.
Agonists were added to the bath manually, with rapid mixing. In experiments using okadaic acid (1 jiM), calyculin (10 IM), vanadate (100 M) and staurosporine (1 RiM), the drugs were added 10 min before addition of ATP while the cells were maintained at 37 °C. In experiments using staurosporine, 100 nM ATP was added to the cells, followed by carbachol RESEARCH PAPER 543
